CHE - CIK 0000019584
The table below shows CHEMED CORP's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $388.27M | $417.50M | $330.30M | $309.89M | $308.60M | $489.29M |
| Capital expenditure | $62.80M | $49.53M | $56.85M | $57.33M | $58.67M | $58.83M |
| Investing cash flow | -$59.34M | -$143.91M | -$60.64M | -$59.40M | -$57.76M | -$61.56M |
| Dividends paid | $31.70M | $27.09M | $23.50M | $22.02M | $22.02M |
CHEMED CORP reported operating cash flow of $388.27M for fiscal year 2025. That is down 7.0% from $417.50M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $135.39M (FY 2016) to $388.27M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $21.08M |
| Stock buybacks | $431.50M | $361.39M | $67.70M | $114.52M | $576.04M | $175.59M |
| Financing cash flow | -$432.77M | -$359.19M | -$79.83M | -$209.25M | -$380.62M | -$271.21M |